Seastar Medical Holding Corporation

01/20/2026 | Press release | Distributed by Public on 01/20/2026 15:03

Material Event (Form 8-K)

Item 8.01. Other Events
Regaining Compliance with the $1.00 Bid Price Rule
On January 20, 2026, the Company received a letter from the Nasdaq Office of General Counsel confirming that the Company has regained compliance with the minimum bid price requirement of the Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule").
Seastar Medical Holding Corporation published this content on January 20, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 20, 2026 at 21:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]